Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

67 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Active, Not Recruiting

A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

NCT04640623

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • Del Sol Research Management, LLC Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Genesis Healthcare Partners - Genesis Research Greater Los Angeles Sherman Oaks, California, United States
  • The Urology Center of Colorado Denver, Colorado, United States
View all 144 locations
View Trial Details
Active, Not Recruiting

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

NCT03459846

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Goodyear, Arizona, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site St. Petersburg, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

NCT04241185

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • Washington Cancer Institute at MedStar Washington Hospital Center ( Site 0041) Washington D.C., District of Columbia, United States
  • Bay Pines VA Medical Center ( Site 0055) Bay Pines, Florida, United States
  • AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlandoc ( Site 0004) Orlando, Florida, United States
  • Norton Cancer Institute ( Site 0044) Louisville, Kentucky, United States
View all 134 locations
View Trial Details
Active, Not Recruiting

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

NCT03661320

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0022 Tucson, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Local Institution - 0021 Littleton, Colorado, United States
  • Local Institution - 0036 Pensacola, Florida, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

NCT07511517

Conditions
Carcinoma, Carcinoma, Transitional Cell, Bladder, Female Urogenital Diseases, +15 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Akershus University Hospital (Ahus) Lørenskog, Norway
  • Oslo University Hospital - Aker Oslo, Norway
  • University Hospital of North Norway (UNN) Tromsø, Norway
View Trial Details
Active, Not Recruiting

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder

NCT06289283

Conditions
Congenital Abnormalities, Congenital Microtia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Theodor Bilharz Research Institute Cairo, Egypt
View Trial Details

Related conditions